Financials data is unavailable for this security.
View more
Year on year Daiken Medical Co Ltd grew revenues 6.71% from 9.14bn to 9.75bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 38.84% net income growth from 712.06m to 988.60m.
| Gross margin | 41.33% |
|---|---|
| Net profit margin | 10.77% |
| Operating margin | 15.45% |
| Return on assets | 9.36% |
|---|---|
| Return on equity | 15.02% |
| Return on investment | 13.25% |
More ▼
Cash flow in JPYView more
In 2024, Daiken Medical Co Ltd increased its cash reserves by 8.86%, or 222.93m. The company earned 1.56bn from its operations for a Cash Flow Margin of 15.95%. In addition the company used 168.77m on investing activities and also paid 1.16bn in financing cash flows.
| Cash flow per share | 44.67 |
|---|---|
| Price/Cash flow per share | 12.50 |
| Book value per share | 253.63 |
|---|---|
| Tangible book value per share | 253.17 |
More ▼
Balance sheet in JPYView more
| Current ratio | 2.36 |
|---|---|
| Quick ratio | 1.90 |
| Total debt/total equity | 0.3381 |
|---|---|
| Total debt/total capital | 0.2527 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.00% and 38.84%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is below the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 3.59% |
|---|---|
| Div growth rate (5 year) | 0.98% |
| Payout ratio (TTM) | 56.93% |
| EPS growth(5 years) | 3.44 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 29.17 |
More ▼
